NEW YORK (GenomeWeb) – Med Fusion today announced an agreement with Highmark to provide diagnostic laboratory services for Highmark's commercial and Medicare Advantage plans.

The agreement will allow Highmark members in Pennsylvania and West Virginia to access Med Fusion's reference laboratory services, as well as molecular testing in oncology, women's health, and urology. Highmark is an affiliate of Blue Cross Blue Shield.

Financial details of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.